| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |